-

Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader to Help Simplify Protein, Cell and Microbial Analysis

Dedicated absorbance reader helps academic, biotech, pharmaceutical and quality control labs generate reliable data for common biological assays with straightforward operation

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, designed to support protein quantification, enzyme-linked immunosorbent assays (ELISAs), cell viability studies, microbial growth monitoring and other routine laboratory applications with simplified operation and dependable performance.

Laboratories performing absorbance-based analysis are under increasing pressure to generate reliable data while managing constrained budgets, shared instrumentation resources and evolving workforce demands. The Multiskan™ Ease was developed specifically for laboratories seeking a dedicated absorbance solution that delivers the capabilities required for common biological assays in a streamlined, easy-to-use platform.

"Many laboratories are looking for technologies that align more closely with their day-to-day workflow requirements," said Trent Colville, Senior Director and General Manager, Protein Detection and Quantification, Thermo Fisher Scientific. "The Multiskan™ Ease was developed to provide the performance researchers need for routine biological analysis in a platform that is easy to adopt, straightforward to operate and designed to support laboratory productivity."

The Multiskan™ Ease supports a range of applications, including protein quantification, enzyme-linked immunosorbent assays (ELISAs), cell viability studies, enzyme activity analysis, endotoxin testing and microbial growth monitoring. The system extends Thermo Fisher's microplate reader portfolio with a solution tailored for academic, biotechnology, pharmaceutical and quality control laboratories focused on routine absorbance measurements.

Frequently Asked Questions

What is the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader?

The Multiskan Ease Absorbance Microplate Reader is a modern, single-mode absorbance microplate reader engineered for routine ELISAs, protein quantification, and colorimetric assays.

What types of laboratories is the Multiskan™ Ease Absorbance Microplate Reader designed for?

The Multiskan™ Ease Absorbance Microplate Reader is designed for academic, biotechnology, pharmaceutical and quality control laboratories that need a straightforward absorbance-based solution for common biological assays.

What applications does the Multiskan™ Ease Absorbance Microplate Reader support?

The Multiskan™ Ease Absorbance Microplate Reader supports routine absorbance applications such as protein quantification, enzyme-linked immunosorbent assays (ELISAs), cell viability studies, enzyme activity analysis, endotoxin testing and microbial growth studies.

How does the Multiskan™ Ease Absorbance Microplate Reader differ from multimode microplate readers?

Unlike multimode systems that support multiple detection technologies, the Multiskan™ Ease Absorbance Microplate Reader is focused on absorbance-based measurements. It is intended for laboratories that need dependable performance for routine absorbance workflows without the added complexity.

Why did Thermo Fisher Scientific develop the Multiskan™ Ease Absorbance Microplate Reader?

Thermo Fisher Scientific developed the Multiskan™ Ease Absorbance Microplate Reader to help laboratories generate reliable data for everyday biological assays while managing practical pressures such as constrained budgets, shared instrumentation resources and evolving workforce demands.

*For research use only. Not for use in diagnostic procedures.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:

Dana Maxwell, Thermo Fisher Scientific
760-859-8539
Dana.Maxwell@thermofisher.com

Tiffany Keenan, Greenough
603-913-3893
tkeenan@greenoughagency.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:

Dana Maxwell, Thermo Fisher Scientific
760-859-8539
Dana.Maxwell@thermofisher.com

Tiffany Keenan, Greenough
603-913-3893
tkeenan@greenoughagency.com

More News From Thermo Fisher

Nalgene Outdoor Expands Mythical Creatures Collection with Mothman, The Loch Ness Monster and Jackalope

ROCHESTER, N.Y.--(BUSINESS WIRE)--Just in time for Halloween, Nalgene Outdoor is adding a little inspiration to spooky season and trick-or-treat traditions with three new designs in its limited-edition Mythical Creatures collection: Mothman, the Loch Ness Monster and Jackalope. The new designs join aliens, werewolves and Sasquatch, bringing six legendary characters to Nalgene’s iconic 32-ounce bottles just in time for fall traditions. Whether they inspire a last-minute Halloween costume, come a...

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026

MILAN--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is expanding its drug development, manufacturing, and clinical capabilities to help pharmaceutical and biotechnology companies navigate increasingly complex paths to commercialization, reduce friction, and maintain momentum. The company will showcase these new and expanded capabilities at CPHI Milan 2026, Oct. 6-8. Among the new offerings is OSD Express, a defined solution designed to increase predictability...

Thermo Fisher Scientific Proteomics Technologies Enable Discovery of More Than 2,500 New Biological Associations in PRECISE-SG100K Study

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its strategic collaboration with Precision Health Research, Singapore (PRECISE) and Nanyang Technological University, Singapore (NTU Singapore) has led to the discovery of more than 2,500 previously unreported genetic-protein associations. By combining Thermo Fisher’s complementary proteomics technologies with PRECISE-SG100K's large-scale health and genomic data, researchers...
Back to Newsroom